Literature DB >> 17619024

Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.

Sean A McKenna1, Darrin A Lindhout, Takashi Shimoike, Colin Echeverría Aitken, Joseph D Puglisi.   

Abstract

Host response to viral RNA genomes and replication products represents an effective strategy to combat viral invasion. PKR is a Ser/Thr protein kinase that binds to double-stranded (ds)RNA, autophosphorylates its kinase domain, and subsequently phosphorylates eukaryotic initiation factor 2alpha (eIF2alpha). This results in attenuation of protein translation, preventing synthesis of necessary viral proteins. In certain DNA viruses, PKR function can be evaded by transcription of highly structured virus-encoded dsRNA inhibitors that bind to and inactivate PKR. We probe here the mechanism of PKR inhibition by two viral inhibitor RNAs, EBER(I) (from Epstein-Barr) and VA(I) (from human adenovirus). Native gel shift mobility assays and isothermal titration calorimetry experiments confirmed that the RNA-binding domains of PKR are sufficient and necessary for the interaction with dsRNA inhibitors. Both EBER(I) and VA(I) are effective inhibitors of PKR activation by preventing trans-autophosphorylation between two PKR molecules. The RNA inhibitors prevent self-association of PKR molecules, providing a mechanistic basis for kinase inhibition. A variety of approaches indicated that dsRNA inhibitors remain associated with PKR under activating conditions, as opposed to activator dsRNA molecules that dissociate due to reduced affinity for the phosphorylated form of PKR. Finally, we show using a HeLa cell extract system that inhibitors of PKR result in translational recovery by the protein synthesis machinery. These data indicate that inhibitory dsRNAs bind preferentially to the latent, dephosphorylated form of PKR and prevent dimerization that is required for trans-autophosphorylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619024      PMCID: PMC3710116          DOI: 10.1016/j.jmb.2007.06.028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  52 in total

1.  Selective binding by the RNA binding domain of PKR revealed by affinity cleavage.

Authors:  R J Spanggord; P A Beal
Journal:  Biochemistry       Date:  2001-04-10       Impact factor: 3.162

2.  Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity.

Authors:  N V Jammi; P A Beal
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 3.  Gene-specific regulation by general translation factors.

Authors:  Thomas E Dever
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 4.  Eukaryotic translation initiation factors and regulators.

Authors:  Nahum Sonenberg; Thomas E Dever
Journal:  Curr Opin Struct Biol       Date:  2003-02       Impact factor: 6.809

5.  The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus.

Authors:  Momchilo Vuyisich; Richard J Spanggord; Peter A Beal
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

6.  Structural basis for recognition of the AGNN tetraloop RNA fold by the double-stranded RNA-binding domain of Rnt1p RNase III.

Authors:  Haihong Wu; Anthony Henras; Guillaume Chanfreau; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

7.  Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2).

Authors:  K M Vattem; K A Staschke; R C Wek
Journal:  Eur J Biochem       Date:  2001-07

8.  The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR.

Authors:  Ulrich-Axel Bommer; Anton V Borovjagin; Martin A Greagg; Ian W Jeffrey; Paul Russell; Kenneth G Laing; Melanie Lee; Michael J Clemens
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

9.  Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR.

Authors:  Yitzhak Ben-Asouli; Yona Banai; Yehuda Pel-Or; Alexei Shir; Raymond Kaempfer
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

Review 10.  PKR activation in neurodegenerative disease.

Authors:  Alyson L Peel
Journal:  J Neuropathol Exp Neurol       Date:  2004-02       Impact factor: 3.685

View more
  21 in total

1.  Analysis of PKR activation using analytical ultracentrifugation.

Authors:  James L Cole
Journal:  Macromol Biosci       Date:  2010-07-07       Impact factor: 4.979

Review 2.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

3.  Specificity of the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR for double-stranded RNA: insights from thermodynamics and small-angle X-ray scattering.

Authors:  Sunita Patel; Joshua M Blose; Joshua E Sokoloski; Lois Pollack; Philip C Bevilacqua
Journal:  Biochemistry       Date:  2012-11-09       Impact factor: 3.162

4.  West Nile virus infection does not induce PKR activation in rodent cells.

Authors:  H Elbahesh; S V Scherbik; M A Brinton
Journal:  Virology       Date:  2011-10-07       Impact factor: 3.616

5.  Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding.

Authors:  Katherine Launer-Felty; James L Cole
Journal:  J Mol Biol       Date:  2014-01-04       Impact factor: 5.469

6.  Analysis of PKR-RNA interactions by sedimentation velocity.

Authors:  C Jason Wong; Katherine Launer-Felty; James L Cole
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.

Authors:  Brenda M Calderon; Graeme L Conn
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

Review 8.  Regulation of innate immunity through RNA structure and the protein kinase PKR.

Authors:  Subba Rao Nallagatla; Rebecca Toroney; Philip C Bevilacqua
Journal:  Curr Opin Struct Biol       Date:  2010-12-08       Impact factor: 6.809

9.  RNAs in Epstein-Barr virions control early steps of infection.

Authors:  Simon Jochum; Romana Ruiss; Andreas Moosmann; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-27       Impact factor: 11.205

10.  RNA dimerization promotes PKR dimerization and activation.

Authors:  Laurie A Heinicke; C Jason Wong; Jeffrey Lary; Subba Rao Nallagatla; Amy Diegelman-Parente; Xiaofeng Zheng; James L Cole; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2009-05-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.